937 related articles for article (PubMed ID: 23619316)
21. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
22. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
23. AKT-ions with a TWIST between EMT and MET.
Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
[TBL] [Abstract][Full Text] [Related]
24. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
25. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
26. Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.
Cao J; Wang X; Dai T; Wu Y; Zhang M; Cao R; Zhang R; Wang G; Jiang R; Zhou BP; Shi J; Kang T
Theranostics; 2018; 8(10):2739-2751. PubMed ID: 29774072
[No Abstract] [Full Text] [Related]
27. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC
Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376
[TBL] [Abstract][Full Text] [Related]
28. Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.
Bocca C; Ievolella M; Autelli R; Motta M; Mosso L; Torchio B; Bozzo F; Cannito S; Paternostro C; Colombatto S; Parola M; Miglietta A
Expert Opin Ther Targets; 2014 Feb; 18(2):121-35. PubMed ID: 24325753
[TBL] [Abstract][Full Text] [Related]
29. Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells.
Huang T; Chen Z; Fang L
Oncol Rep; 2013 Jan; 29(1):117-24. PubMed ID: 23076367
[TBL] [Abstract][Full Text] [Related]
30. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
[TBL] [Abstract][Full Text] [Related]
31. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
32. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
33. Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer.
Ravindranath A; Yuen HF; Chan KK; Grills C; Fennell DA; Lappin TR; El-Tanani M
Br J Cancer; 2011 Aug; 105(4):542-51. PubMed ID: 21772333
[TBL] [Abstract][Full Text] [Related]
34. Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.
He Q; Gong Y; Gower L; Yang X; Friesel RE
J Cell Biochem; 2016 Oct; 117(10):2346-56. PubMed ID: 26950413
[TBL] [Abstract][Full Text] [Related]
35. IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.
Su P; Hu J; Zhang H; Li W; Jia M; Zhang X; Wu X; Cheng H; Xiang L; Zhou G
Int J Clin Exp Pathol; 2014; 7(6):3008-17. PubMed ID: 25031719
[TBL] [Abstract][Full Text] [Related]
36. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
37. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
[TBL] [Abstract][Full Text] [Related]
38. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
39. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
